Published in
American Chemical Society, Journal of Medicinal Chemistry, 17(66), p. 12203-12224, 2023
DOI: 10.1021/acs.jmedchem.3c00795
Links
Tools
Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders
Journal article published in 2023 by
Susanne Roehrig 
,
Jens Ackerstaff,
Eloísa Jiménez Núñez,
Henrik Teller,
Pascal Ellerbrock,
Katharina Meier ,
Stefan Heitmeier,
Adrian Tersteegen,
Jan Stampfuss,
Dieter Lang ,
Karl-Heinz Schlemmer,
Martina Schaefer,
Kersten M. Gericke,
Tom Kinzel,
Daniel Meibom
and other authors.
,
Jens Ackerstaff,
Eloísa Jiménez Núñez,
Henrik Teller,
Pascal Ellerbrock,
Katharina Meier ,
Stefan Heitmeier,
Adrian Tersteegen,
Jan Stampfuss,
Dieter Lang ,
Karl-Heinz Schlemmer,
Martina Schaefer,
Kersten M. Gericke,
Tom Kinzel,
Daniel Meibom
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving allowed
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Postprint:
archiving restricted
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Published version:
archiving forbidden
Data provided by 